UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on Team Health Holdings on Solid Q4 Results

In a report published Friday, Goldman Sachs reiterated its Neutral rating on Team Health Holdings

, and raised its price target from $30.00 to $33.00. Goldman Sachs noted, “TMH reported 4Q EPS of $0.39 vs. our/Street estimate of $0.40/$0.36 with revenues and adjusted EBITDA largely in line with our estimates. Revenues grew 18% yoy largely driven by acquisition (10.9% yoy) and strong FFS volume growth (5.5% yoy). The strong FFS growth can be attributed to an early start to the flu season in December. Adjusted EBITDA margin of 9.9% increased 40 bps yoy and was slightly ahead of our 9.7% estimate. For 2013, management issued revenue growth guidance of 13-14% and adjusted EBITDA margin of 10.5%. The guidance excludes potential benefit from Medicaid parity.” Team Health Holdings closed on Thursday at $34.20.